← Back to Search

Paramedic Coaching for Dementia (CP3D Trial)

N/A
Waitlist Available
Led By Manish N Shah, MD, MPH
Research Sponsored by University of Wisconsin, Madison
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosis or indication in medical record of mild to moderate dementia (any subtype)
English speaking
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 24 months
Awards & highlights

CP3D Trial Summary

This trial will study whether a community paramedic coaching program can help caregivers of people with dementia, in coordination with the participant's primary health care team.

CP3D Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

CP3D Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Feasibility: Proportion of Coaching Home Visits Completed
Feasibility: Proportion of Coaching Phone Calls Completed
Number of Visits to the Emergency Department by the Caregiver of the Person With Dementia
+1 more
Secondary outcome measures
Change in Caregiver Perceptions About Communication With Clinical Team Members (CAPACITY) Measure
Change in Caregiver Quality of Life (C-DEMQOL) Score
Change in Center for Epidemiologic Studies Depression Scale (CESD-10)
+8 more

CP3D Trial Design

1Treatment groups
Experimental Treatment
Group I: Paramedic CoachingExperimental Treatment1 Intervention
The intervention is an adaptation of the evidence-based REACH program
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Paramedic Coaching
2020
N/A
~20

Find a Location

Who is running the clinical trial?

University of Wisconsin, MadisonLead Sponsor
1,177 Previous Clinical Trials
3,012,142 Total Patients Enrolled
8 Trials studying Dementia
1,816 Patients Enrolled for Dementia
National Institute on Aging (NIA)NIH
1,658 Previous Clinical Trials
28,004,429 Total Patients Enrolled
263 Trials studying Dementia
23,622,992 Patients Enrolled for Dementia
Manish N Shah, MD, MPHPrincipal InvestigatorUniversity of Wisconsin, Madison
1 Previous Clinical Trials
1,979 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~4 spots leftby Mar 2025